How Do You Tailor Healthcare Affordability?
A healthcare CEO shares how personalized financial solutions can ease the burden on both patients and providers
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Key takeaways
A healthcare CEO shares how personalized financial solutions can ease the burden on both patients and providers
Healthcare Rethink, a FinThrive podcast, addresses the pressing issue of healthcare affordability. Host Brian Urban engages with Srulik Dvorsky, Co-Founder & CEO of TailorMed, in a discussion that unpacks the practicalities of reducing the financial burden of medical expenses on patients and providers alike. With a background in medical devices and a personal connection to the healthcare struggles of loved ones, Dvorsky provides a business-oriented narrative of his shift to developing TailorMed's innovative platform.
The podcast explores TailorMed's core functionalities, highlighting how its approach extends beyond simple payment assistance to a comprehensive affordability strategy. "We're building a network that sees patients everywhere they are prescribed their medication, effectively removing the signature barrier to treatment," Dvorsky explained.
We're building a network that sees patients everywhere they are prescribed their medication, effectively removing the signature barrier to treatment.— Srulik Dvorsky, Co-Founder & CEO at TailorMed
This episode summarizes TailorMed's role in reshaping healthcare's economic landscape through its analytical tools and network, painting a picture of a future where technology and empathy converge to ease the cost of healthcare.
Episode Highlights:
- Dvorsky's transition from medical device innovation to healthcare affordability solutions
- TailorMed’s analytics platform and its role in enhancing patient care through improved financial navigation and support
- Insights into TailorMed's Affordability Network and its potential to transform patient experiences by reducing the financial toxicity of medical treatments
Srulik Dvorsky co-founded TailorMed and leads the company as its CEO, steering it to be a leader in healthcare affordability solutions. He brings over a decade of experience from the medical device sector, where he led the development of an innovative treatment for ischemic stroke—a breakthrough implantable neurostimulator. Dvorsky's technical expertise runs in tandem with his commitment to healthcare, shaped by his active role as a caregiver to family members with critical illnesses. This dual perspective has given him a profound understanding of the healthcare challenges patients and providers face, fueling his dedication to making healthcare more accessible and affordable.
About the author
Brian Urban has a deep skill set in health promotion and product development for rare disease and senior populations with Large Health Plans and Specialty Pharmacy. Urban has served as a speaker on such topics for the Alzheimer’s Association, Obediah Cole Prostate Cancer Foundation, Cigna Corp and Utica University Institute for the study of integrative healthcare. Urban has received a Masters of Science in Exercise Physiology-Health Promotion, Masters of Business Administration in Market Development and is currently completing a Masters in Public Health at Dartmouth College. Urban is currently a research-fellow sponsored by a Robert Wood Johnson Grant supporting Utica University public health research in Upstate New York.
